Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Received: 3 June 2020
Accepted: 16 November 2020
First Online: 17 March 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: LJS has received speaking fees from Mylan and Sanofi, and has received clinical trial support from Optinose, Astra Zeneca, GSK, and Roche.
